X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33) 33
humans (32) 32
female (26) 26
hiv infections - prevention & control (23) 23
prevention (21) 21
adult (20) 20
human immunodeficiency virus--hiv (20) 20
tenofovir (20) 20
infectious diseases (18) 18
hiv prevention (17) 17
clinical trials (16) 16
women (16) 16
research (15) 15
adherence (14) 14
hiv infection (14) 14
adenine - analogs & derivatives (13) 13
young adult (13) 13
adenine - administration & dosage (12) 12
anti-hiv agents - administration & dosage (12) 12
gels (12) 12
microbicides (12) 12
organophosphonates - administration & dosage (12) 12
social sciences, biomedical (12) 12
south africa (12) 12
article (11) 11
hiv (11) 11
public health (11) 11
medicine (10) 10
preexposure prophylaxis (10) 10
public, environmental & occupational health (10) 10
administration, intravaginal (9) 9
analysis (9) 9
infection (9) 9
medicine & public health (9) 9
preventive medicine (9) 9
adolescent (8) 8
antimicrobial agents (8) 8
compliance (8) 8
health aspects (8) 8
health psychology (8) 8
immunology (8) 8
transmission (8) 8
anti-hiv agents - therapeutic use (7) 7
disease prevention (7) 7
sexually transmitted diseases (7) 7
acquired immune deficiency syndrome--aids (6) 6
aids/hiv (6) 6
anti-infective agents (6) 6
dosage and administration (6) 6
double-blind method (6) 6
efficacy (6) 6
hiv infections - virology (6) 6
male (6) 6
medication adherence (6) 6
medicine, research & experimental (6) 6
pharmacology & pharmacy (6) 6
pre-exposure prophylaxis (6) 6
south-africa (6) 6
acceptability (5) 5
challenges (5) 5
cytokines (5) 5
double-blind (5) 5
drug therapy (5) 5
follow-up studies (5) 5
hiv infections - epidemiology (5) 5
infections (5) 5
inflammation (5) 5
medication adherence - psychology (5) 5
patient compliance (5) 5
prophylaxis (5) 5
studies (5) 5
tenofovir gel (5) 5
treatment outcome (5) 5
vagina (5) 5
vaginal gel (5) 5
virology (5) 5
adenine - adverse effects (4) 4
animals (4) 4
anti-infective agents - administration & dosage (4) 4
anti-infective agents, local - administration & dosage (4) 4
antiretroviral therapy (4) 4
care and treatment (4) 4
clinical-trials (4) 4
counseling (4) 4
health risks (4) 4
hiv infections - drug therapy (4) 4
incidence (4) 4
medical research (4) 4
men (4) 4
microbicide (4) 4
motivation (4) 4
multidisciplinary sciences (4) 4
organophosphonates - adverse effects (4) 4
pharmacology (4) 4
pregnancy (4) 4
reverse transcriptase inhibitors - administration & dosage (4) 4
risk (4) 4
risk assessment (4) 4
risk factors (4) 4
sexual behavior (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 9/2010, Volume 329, Issue 5996, pp. 1168 - 1174
The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of... 
Human sexual behavior | HIV infections | Antiinfectives | Gels | HIV | RESEARCH ARTICLES | Placebos | Experimentation | AIDS | Infections | Condoms | VAGINAL GEL | INDIVIDUALS | SOUTH-AFRICA | PROPHYLAXIS | IN-VITRO | TRANSMISSION | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | MALE CIRCUMCISION | RANDOMIZED CONTROLLED-TRIAL | CHALLENGES | HIV Infections - prevention & control | Anti-Infective Agents, Local - therapeutic use | Urban Population - statistics & numerical data | HIV Infections - epidemiology | Humans | Anti-Infective Agents, Local - adverse effects | Drug Resistance, Viral | Administration, Intravaginal | Viral Load | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | HIV-1 - physiology | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Vaginal Creams, Foams, and Jellies | Rural Population - statistics & numerical data | Sexual Behavior | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | South Africa - epidemiology | Organophosphonates - adverse effects | Adenine - administration & dosage | Pregnancy | Organophosphonates - administration & dosage | Anti-Infective Agents, Local - administration & dosage | Adolescent | Patient Compliance | Pregnancy Outcome | Prevention | Anti-infective agents | Research | HIV infection
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 6, pp. 530 - 539
Journal Article
Nature Medicine, ISSN 1078-8956, 05/2018, Volume 24, Issue 4, pp. 491 - 496
Journal Article
AIDS Care, ISSN 0954-0121, 06/2017, Volume 29, Issue 6, pp. 734 - 740
Young women bear a disproportionately high burden of HIV infection in sub-Saharan Africa, prioritising pre-exposure prophylaxis (PrEP) can be an integral part... 
Pre-exposure prophylaxis | market segmentation | participatory research | PSYCHOLOGY, MULTIDISCIPLINARY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIV | SOCIAL SCIENCES, BIOMEDICAL | PREVENTION | ACCEPTABILITY | HEALTH POLICY & SERVICES | HIV Infections - prevention & control | Self Efficacy | Sexual Behavior | Gels | Tenofovir - therapeutic use | Humans | Middle Aged | Suburban Population | Urban Population | Pre-Exposure Prophylaxis | Young Adult | Patient Acceptance of Health Care | Rural Population | Adolescent | Adult | Anti-HIV Agents - therapeutic use | Female | South Africa | Positioning | Segmentation | Rural communities | Prophylaxis | Spatial discrimination | Clinical trials | Social class | Promotion | Preventive health care | Acceptability | Rural differences | Marketing | Sex education | Prevention | Tenofovir | Sexually transmitted diseases | Microbicides | Social interactions | Technology | Human immunodeficiency virus--HIV | Rural-Urban differences | Participatory action research | Women | Preventive strategies | Medical research | At risk | Urban areas | Rural areas | Health risks | Market segmentation | Clinical research | Data processing | Discussion groups | Workshops | Exposure | Associations | Uptake | Infection | Disease prevention | Social status | Safe sexual practices | Gays & lesbians | Spatial location
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 07/2015, Volume 61, Issue 2, pp. 260 - 269
Background. Women in Africa, especially young women, have very high human immunodeficiency virus (HIV) incidence rates that cannot be fully explained by... 
cytokine | female genital tract | inflammation | HIV transmission | INFECTIOUS DISEASES | METAANALYSIS | RANTES | TRACT INFLAMMATION | ALPHA | MICROBIOLOGY | IMMUNOLOGY | CERVIX | SEXUALLY-TRANSMITTED INFECTIONS | TYPE-1 | Interleukin-6 - analysis | Chemokines - blood | Vaginitis - diagnosis | Chemokine CCL2 - immunology | Cytokines - analysis | Humans | Tumor Necrosis Factor-alpha - blood | Vagina - immunology | Genitalia, Female - virology | Young Adult | HIV Infections - immunology | Interleukin-6 - blood | Vaginal Douching | Tumor Necrosis Factor-alpha - immunology | Female | HIV Infections - transmission | Inflammation - diagnosis | Interleukin-8 - blood | Cytokines - genetics | Interleukin-10 - analysis | Chemokines - immunology | Cytokines - blood | Cytokines - immunology | Disease Susceptibility | Genitalia, Female - immunology | HIV Infections - virology | Africa | Chemokine CCL2 - blood | Chemokines - genetics | Interleukin-8 - analysis | Tumor Necrosis Factor-alpha - analysis | Chemokines - analysis | Interferon-gamma - analysis | Sexually Transmitted Diseases | Uterine Cervicitis - diagnosis | Interferon-gamma - immunology | Cervix Uteri - immunology | Interleukin-6 - immunology | Genital Diseases, Female - diagnosis | South Africa | Interleukin-8 - immunology | Interleukin-10 - immunology | Chemokine CCL2 - analysis | Interferon-gamma - blood | Reproductive organs, Female | Complications and side effects | Young women | Inflammation | Research | Health aspects | HIV infection | Risk factors | AIDS | HIV
Journal Article
AIDS and Behavior, ISSN 1090-7165, 5/2014, Volume 18, Issue 5, pp. 811 - 819
High adherence is key to microbicide effectiveness. Here we provide a description of adherence interventions and the adherence rates achieved in the CAPRISA... 
Adherence | Public Health | Microbicides | Medicine & Public Health | Infectious Diseases | Clinical trial | Health Psychology | Adherence measures | HIV prevention | Adherence support | VAGINAL GEL | INFORMATION | SOCIAL SCIENCES, BIOMEDICAL | PREVENTION | ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | MOTIVATION | WOMEN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIV-INFECTION | CLINICAL-TRIALS | BEHAVIORAL SKILLS MODEL | HIV Infections - prevention & control | Urban Population - statistics & numerical data | Follow-Up Studies | HIV Infections - epidemiology | Humans | Administration, Intravaginal | Socioeconomic Factors | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Counseling | Adult | Female | HIV Infections - transmission | Motivational Interviewing | Rural Population - statistics & numerical data | Adenine - analogs & derivatives | Double-Blind Method | HIV-1 - drug effects | Gels - administration & dosage | HIV Infections - virology | South Africa - epidemiology | Kaplan-Meier Estimate | Sexual Behavior - statistics & numerical data | Treatment Outcome | Adenine - administration & dosage | Organophosphonates - administration & dosage | Medication Adherence | Anti-Infective Agents, Local - administration & dosage | Clinical trials | Dosage and administration | Research | Women | Antimicrobial agents | Preventive medicine | Compliance | Human immunodeficiency virus--HIV | clinical trial | adherence support | adherence | adherence measures
Journal Article